CST BLOG

The official blog of Cell Signaling Technology, where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Emma Mason

Emma Mason

Emma Mason is the founder and director of Cambridge Technical Content Ltd, based in the U.K. With over 25 years' experience in the life sciences industry, she produces online content covering a diverse range of topics and has contributed to many of the Hallmarks of Cancer blogs published by CST.

Recent Posts:

Inflammasome Therapeutics: How the Inflammasome Pathway is Being Targeted to Treat Chronic Diseases

Despite having essential roles in immune defense and tissue repair, inflammasomes contribute to the ...

How the Inflammasome Drives Disease: Tackling Aberrant Inflammasome Signaling

Non-communicable diseases such as neurodegeneration, metabolic disorders, and autoimmune disease are...

    Recent Posts